U.S. bans travel from three African countries as Ebola outbreak spreads

At least six Americans are believed to have been exposed to the Ebola virus, and one person who appears to have contracted the virus has been evacuated to Germany

By Adam Kovac edited by Claire Cameron

A visitor washes his hands before entering Kyeshero Hospital at a checkpoint for hand washing and temperature screening for all visitors and patients entering Kyeshero Hospital, as part of Ebola prevention measures in Goma on May 18, 2026. — Photo by Jospin Mwisha / AFP via Getty Images

Join Our Community of Science Lovers!

The U.S. on Monday announced new travel restrictions on visitors from three African nations—Uganda, South Sudan and the Democratic Republic of the Congo (DRC), which are at the center of an ongoing outbreak of Ebola virus that is believed to have killed at least 100 people. The ban, which doesn’t apply to U.S. citizens or permanent residents, will remain in place for 30 days. At least six Americans are known to have been exposed to the virus in the DRC; one of these people developed symptoms and has been evacuated to Germany, according to U.S. officials.

In an order signed by acting Centers for Disease Control and Prevention (CDC) head Jay Bhattacharya, the agency says the ban aims to minimize the potential for spillover into the U.S. and to buy officials time to assess the threat of the outbreak, which the World Health Organization (WHO) on Sunday declared a global health emergency. While there have been just a dozen or so confirmed infections, hundreds more are suspected.

The U.S. will also step up health screening, and the CDC will try to contact trace anyone who may have entered the country in recent weeks that could have had any exposure to Ebola. The risk to the general public remains low, the agency said in a press conference on Monday.

On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.

The outbreak appears to be driven by the Bundibugyo virus, one of several viruses that can cause Ebola disease. The most notable symptom is viral hemorrhagic fever, which can cause life-threatening internal bleeding. This type of Ebola is similar to but not the same as the Zaire strain of the virus, which caused the 2013–2016 Ebola epidemic in West Africa that killed at least 11,325 people. The mortality rate for Bundibugyo is 25 percent to 50 percent, according to the CDC, and there is no vaccine or specific therapeutic for the disease.

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American